Methyl cholate

Overview

Methyl cholate is a bile acid analog and a specific inhibitor of TcdB toxin from Clostridioides difficile . Methyl cholate exerts a stronger selective inhibitory effect on TcdB than on TcdA . Methyl cholate induces conformational stabilization by binding to a unique site of TcdB, thereby blocking the binding of the toxin to host receptors and its self-processing process. Methyl cholate effectively protects human fibroblasts from TcdB-induced cytopathic effects. Methyl cholate exhibits dose-dependent anti-hepatic fibrosis activity in both cellular and zebrafish models, and significantly reduces the expression levels of α-SMA and COL-I . Methyl cholate is suitable for in-depth research in the fields of Clostridioides difficile infection and hepatic fibrosis.

Application

Products | Products > Disease Areas > Hepatic Fibrosis | Products > Disease Areas > Infection | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Liver Disease | Products > Disease Areas > Bacterial Infection | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Cytoskeleton | Products > Research Areas > Metabolic Disease | Products > Research Areas > Infection | Products > Signaling Pathways > Endogenous Metabolite | Products > Signaling Pathways > Collagen

Product Information

• Catalog No.: HY-107830
• CAS No.: 1448-36-8
• Molecular Formula: C25H42O5
• Molecular Weight: 422.60
• Purity: 99.81%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
• Solubility: ≥ 2.5 mg/mL (5.92 mM); Clear solution
• Availability: In-stock

Source

Original product source